Headlines about Healthcare Trust Of America (NYSE:HTA) have trended somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Healthcare Trust Of America earned a news sentiment score of 0.18 on Accern’s scale. Accern also gave media headlines about the real estate investment trust an impact score of 46.8375696831495 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:
- PIASC Selects Jack Stoughton, Jr., Executive of the Year (whattheythink.com)
- Healthcare Trust of America (HTA) Names Roberta B. Bowman to Board (streetinsider.com)
- Healthcare Trust Of America Inc (HTA) Given Consensus Recommendation of “Buy” by Analysts (americanbankingnews.com)
- $175.73 Million in Sales Expected for Healthcare Trust Of America Inc (HTA) This Quarter (americanbankingnews.com)
- Healthcare Trust of America, Inc. Supports The 2018 “Success Starts With Hope Breakfast” For Boys Hope Girls Hope Of Arizona (finance.yahoo.com)
A number of analysts have issued reports on HTA shares. TheStreet downgraded shares of Healthcare Trust Of America from a “b-” rating to a “c+” rating in a report on Monday, December 11th. Raymond James Financial downgraded shares of Healthcare Trust Of America from a “strong-buy” rating to an “outperform” rating and cut their price objective for the company from $34.00 to $30.00 in a report on Tuesday, February 27th. Zacks Investment Research cut shares of Healthcare Trust Of America from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. SunTrust Banks set a $33.00 price objective on shares of Healthcare Trust Of America and gave the stock a “buy” rating in a research report on Monday, January 22nd. Finally, BMO Capital Markets reiterated a “buy” rating and set a $33.00 price objective on shares of Healthcare Trust Of America in a research report on Tuesday, January 9th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $32.40.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 10th. Stockholders of record on Tuesday, April 3rd will be issued a $0.305 dividend. The ex-dividend date is Monday, April 2nd. This represents a $1.22 annualized dividend and a dividend yield of 4.68%. Healthcare Trust Of America’s dividend payout ratio is currently 369.70%.
COPYRIGHT VIOLATION NOTICE: “Somewhat Positive Press Coverage Somewhat Unlikely to Affect Healthcare Trust Of America (NYSE:HTA) Stock Price” was first published by BBNS and is owned by of BBNS. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://baseballnewssource.com/2018/03/16/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-healthcare-trust-of-america-hta-share-price/1986038.html.
About Healthcare Trust Of America
Healthcare Trust of America, Inc is a real estate investment trust. The Company is an owner and operator of medical office buildings (MOBs) in the United States. The Company focuses on owning and operating MOBs that serve healthcare delivery and are located on health system campuses, near university medical centers, or in community core outpatient locations.
Receive News & Ratings for Healthcare Trust Of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Trust Of America and related companies with MarketBeat.com's FREE daily email newsletter.